Vaxart Inc
(STU:NB11)
€
0.852
0.0325 (3.97%)
Market Cap: 193.86 Mil
Enterprise Value: 154.51 Mil
PE Ratio: 0
PB Ratio: 2.69
GF Score: 48/100 Vaxart Inc (STU:NB11) Transcripts
- Q1 2024 Vaxart Inc Earnings Call TranscriptMay 13, 2024€0.761 (+18.35%)Earnings
- Q4 2023 Vaxart Inc Earnings Call TranscriptMar 14, 2024€1.02 (+0.64%)Earnings
- Q3 2023 Vaxart Inc Earnings Call TranscriptNov 02, 2023€0.6232 (+5.63%)Earnings
- Vaxart Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Vaxart Inc Topline Results Conference Call TranscriptSep 06, 2023
- Q2 2023 Vaxart Inc Earnings Call TranscriptAug 03, 2023€0.7008 (+0.40%)Earnings
- Vaxart Inc Annual Shareholders Meeting TranscriptJun 26, 2023
- Q1 2023 Vaxart Inc Earnings Call TranscriptMay 04, 2023€0.8002 (+7.61%)Earnings
- Q4 2022 Vaxart Inc Earnings Call TranscriptMar 15, 2023€0.7266 (+0.78%)Earnings
- Q3 2022 Vaxart Inc Earnings Call TranscriptNov 08, 2022€1.47 (+0.71%)Earnings
- Vaxart Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Vaxart Inc to Host COVID-19 Phase II Top-line Results TranscriptSep 01, 2022
- Q2 2022 Vaxart Inc Earnings Call TranscriptAug 08, 2022€4.19 (+8.54%)Earnings
- Vaxart Inc to Host Investor Q&A Webcast TranscriptJun 22, 2022
- Vaxart Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Q4 2020 Vaxart Inc Earnings Call TranscriptMar 02, 2021€6 (-0.83%)Earnings
- 1